Mitolyn's effectiveness has sparked greater interest in research on mitochondrial health as an essential component of weight ...

Novo Nordisk has defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an “important” weight loss treatment.

Are we truly on the brink of a cure for obesity? Or could neglecting the root causes risk worsening the very problems we seek ...

Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

Novo Nordisk has licensed an oral obesity drug that works via an uncommon mechanism and may help patients maintain their ...

But resistant starch can help you feel full after a meal, and that may lower the risk you’ll overeat, Cording says. Resistant ...

In conclusion, while the keto diet may appear appealing for quick weight loss or other health claims, this review suggests ...

A new medical database automatically compiles the medical records of obese patients and those suffering from obesity-related diseases in a uniquely comprehensive and reliable manner.

In today’s fast-paced lifestyle, where wellness often takes a back seat, individuals are continuously seeking effective ...

As artificial intelligence continues to evolve, especially here in the Bay Area, one lab is working to use AI technology to find the next effective weight loss drug.

As more people lose weight using medications like Ozempic, Wegovy and Mounjaro, food companies ramp up their efforts to keep ...